Research recommendation(s) from an individual piece of guidance
|Guidance||Neonatal infection (early onset): antibiotics for prevention and treatment|
|Date issued||August 2012|
Research recommendations coming out of this guidance
- Screening and intrapartum antibiotic prophylaxis for group B streptococcal colonisation:- What is the clinical and cost effectiveness of intrapartum antibiotic prophylaxis targeting group B streptococcus and guided by routine antenatal screening?
- Risk factors for early-onset neonatal infection and symptoms and signs:- Which risk factors for early-onset neonatal infection, clinical symptoms and signs of infection, and laboratory investigations should be used to identify babies who should receive antibiotics?
- Intrapartum antibiotic prophylaxis in preterm labour:- What is the clinical and cost effectiveness of intrapartum antibiotic prophylaxis using benzylpenicillin in women with preterm labour?
- Investigations during antibiotic treatment:- What is the clinical and cost effectiveness of laboratory investigations used individually or in combination to exclude early-onset neonatal infection in babies receiving antibiotics for suspected infection?
- Duration of antibiotic treatment:- What is the optimal duration of treatment (course length) in babies who receive antibiotics for confirmed early-onset neonatal infection?